said in a statement. Merilog is the first rapid-acting biosimilar human analog insulin approved by FDA. Since March 2020, FDA has regulated insulin and a subset of other biological products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback